


Robocath raises €5 million and announces the appointment of Lucien Goffart as new CEO

CarThera receives FDA approval for Phase 1/2a trial in glioblastoma

CarThera appoints Pascal E. R. Girin as chairman of board of directors

Vygon Asia donates chemo ports to Mount Miriam Cancer Hospital in Malaysia

Robocath strengthens its medical advisory board with international interventional cardiology experts

SafeHeal obtains CE-mark for Colovac, its novel endoluminal bypass sheath

CarThera publishes complete results of Phase I/IIa clinical trial using its SonoCloud-1 ultrasound implant for treatment of glioblastoma

HypnoVR confirms validity of virtual reality hypnosis through three clinical studies
